Nasdaq
HBIO
Harvard Bioscience, Inc.
- Industrials
- Listed 2000
- 1 day
- −2.8%
- 1 month
- −6.6%
- 1 year
- +22.6%
$6.19 · Mkt cap $27.9M
At the 6 Aug 2026 close
Nasdaq
Harvard Bioscience, Inc.
$6.19 · Mkt cap $27.9M
At the 6 Aug 2026 close
Harvard Bioscience, Inc. trades under the ticker HBIO on Nasdaq, in the Industrials sector (Biotechnology: Laboratory Analytical Instruments). It has been listed since 2000. Its market capitalisation is $27.9M. The last closing price was $6.19, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +22.6%, and −6.6% over the past month. Returns are price returns and exclude dividends.
This page exists because HBIO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.